Annual CFI
$442.91 M
+$117.48 M+36.10%
December 31, 2023
Summary
- As of February 7, 2025, SAGE annual cash flow from investing activities is $442.91 million, with the most recent change of +$117.48 million (+36.10%) on December 31, 2023.
- During the last 3 years, SAGE annual CFI has risen by +$229.00 thousand (+0.05%).
- SAGE annual CFI is now at all-time high.
Performance
SAGE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$81.05 M
+$81.44 M+21098.45%
September 30, 2024
Summary
- As of February 7, 2025, SAGE quarterly cash flow from investing activities is $81.05 million, with the most recent change of +$81.44 million (+21098.45%) on September 30, 2024.
- Over the past year, SAGE quarterly CFI has increased by +$81.44 million (+21098.45%).
- SAGE quarterly CFI is now -60.99% below its all-time high of $207.78 million, reached on September 30, 2019.
Performance
SAGE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$262.17 M
-$79.34 M-23.23%
September 30, 2024
Summary
- As of February 7, 2025, SAGE TTM cash flow from investing activities is $262.17 million, with the most recent change of -$79.34 million (-23.23%) on September 30, 2024.
- Over the past year, SAGE TTM CFI has dropped by -$79.34 million (-23.23%).
- SAGE TTM CFI is now -54.29% below its all-time high of $573.51 million, reached on June 30, 2020.
Performance
SAGE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SAGE Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.1% | +10000.0% | -23.2% |
| 3 y3 years | +0.1% | +424.4% | +128.3% |
| 5 y5 years | +186.4% | -61.0% | +283.1% |
SAGE Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +144.2% | -58.4% | +367.9% | -50.5% | +126.2% |
| 5 y | 5-year | at high | +144.2% | -60.7% | +112.3% | -54.3% | +126.2% |
| alltime | all time | at high | +144.2% | -61.0% | +112.3% | -54.3% | +126.2% |
Sage Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $81.05 M(<-9900.0%) | $262.17 M(-23.2%) |
| Jun 2024 | - | -$386.00 K(-100.3%) | $341.50 M(-11.9%) |
| Mar 2024 | - | $139.44 M(+231.5%) | $387.48 M(-12.5%) |
| Dec 2023 | $442.91 M(+36.1%) | $42.06 M(-73.8%) | $442.91 M(-9.7%) |
| Sep 2023 | - | $160.39 M(+251.8%) | $490.63 M(+11.2%) |
| Jun 2023 | - | $45.59 M(-76.6%) | $441.19 M(-16.7%) |
| Mar 2023 | - | $194.87 M(+117.1%) | $529.86 M(+62.8%) |
| Dec 2022 | $325.43 M(-132.5%) | $89.78 M(-19.1%) | $325.43 M(+58.4%) |
| Sep 2022 | - | $110.95 M(-17.4%) | $205.40 M(+195.7%) |
| Jun 2022 | - | $134.26 M(-1504.7%) | $69.46 M(-119.7%) |
| Mar 2022 | - | -$9.56 M(-68.4%) | -$353.19 M(-64.8%) |
| Dec 2021 | -$1.00 B(-326.4%) | -$30.26 M(+21.1%) | -$1.00 B(+8.2%) |
| Sep 2021 | - | -$24.98 M(-91.3%) | -$926.67 M(+4.3%) |
| Jun 2021 | - | -$288.39 M(-56.2%) | -$888.17 M(+110.3%) |
| Mar 2021 | - | -$658.82 M(-1547.3%) | -$422.40 M(-195.4%) |
| Dec 2020 | $442.68 M(-409.2%) | $45.52 M(+236.9%) | $442.68 M(+16.7%) |
| Sep 2020 | - | $13.51 M(-92.4%) | $379.25 M(-33.9%) |
| Jun 2020 | - | $177.38 M(-14.0%) | $573.51 M(+69.7%) |
| Mar 2020 | - | $206.27 M(-1251.3%) | $338.02 M(-336.1%) |
| Dec 2019 | -$143.16 M(-72.1%) | -$17.92 M(-108.6%) | -$143.16 M(+64.9%) |
| Sep 2019 | - | $207.78 M(-457.6%) | -$86.82 M(-70.5%) |
| Jun 2019 | - | -$58.11 M(-78.9%) | -$294.55 M(-37.9%) |
| Mar 2019 | - | -$274.91 M(-815.6%) | -$474.57 M(-7.4%) |
| Dec 2018 | -$512.46 M | $38.42 M(>+9900.0%) | -$512.46 M(-21.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $52.00 K(-100.0%) | -$655.48 M(+7.2%) |
| Jun 2018 | - | -$238.13 M(-23.9%) | -$611.66 M(+85.9%) |
| Mar 2018 | - | -$312.80 M(+199.0%) | -$328.94 M(-2227.4%) |
| Dec 2017 | $15.46 M(-106.7%) | -$104.60 M(-338.4%) | $15.46 M(+627.3%) |
| Sep 2017 | - | $43.87 M(-1.6%) | $2.13 M(-103.1%) |
| Jun 2017 | - | $44.59 M(+41.1%) | -$69.47 M(-64.9%) |
| Mar 2017 | - | $31.60 M(-126.8%) | -$198.07 M(-13.9%) |
| Dec 2016 | -$230.01 M(>+9900.0%) | -$117.94 M(+325.5%) | -$230.01 M(+105.2%) |
| Sep 2016 | - | -$27.72 M(-67.0%) | -$112.11 M(+32.9%) |
| Jun 2016 | - | -$84.02 M(>+9900.0%) | -$84.37 M(>+9900.0%) |
| Mar 2016 | - | -$341.00 K(+797.4%) | -$429.00 K(+116.7%) |
| Dec 2015 | -$198.00 K(+54.7%) | -$38.00 K(-281.0%) | -$198.00 K(-3.4%) |
| Sep 2015 | - | $21.00 K(-129.6%) | -$205.00 K(-32.6%) |
| Jun 2015 | - | -$71.00 K(-35.5%) | -$304.00 K(+29.4%) |
| Mar 2015 | - | -$110.00 K(+144.4%) | -$235.00 K(+83.6%) |
| Dec 2014 | -$128.00 K(+4166.7%) | -$45.00 K(-42.3%) | -$128.00 K(+54.2%) |
| Sep 2014 | - | -$78.00 K(+3800.0%) | -$83.00 K(+1560.0%) |
| Jun 2014 | - | -$2000.00(-33.3%) | -$5000.00(+66.7%) |
| Mar 2014 | - | -$3000.00(<-9900.0%) | -$3000.00(0.0%) |
| Dec 2013 | -$3000.00(-97.3%) | $0.00(0.0%) | -$3000.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | -$3000.00(0.0%) |
| Jun 2013 | - | $0.00(-100.0%) | -$3000.00(0.0%) |
| Mar 2013 | - | -$3000.00 | -$3000.00 |
| Dec 2012 | -$111.00 K | - | - |
FAQ
- What is Sage Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Sage Therapeutics?
- What is Sage Therapeutics annual CFI year-on-year change?
- What is Sage Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Sage Therapeutics?
- What is Sage Therapeutics quarterly CFI year-on-year change?
- What is Sage Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Sage Therapeutics?
- What is Sage Therapeutics TTM CFI year-on-year change?
What is Sage Therapeutics annual cash flow from investing activities?
The current annual CFI of SAGE is $442.91 M
What is the all time high annual CFI for Sage Therapeutics?
Sage Therapeutics all-time high annual cash flow from investing activities is $442.91 M
What is Sage Therapeutics annual CFI year-on-year change?
Over the past year, SAGE annual cash flow from investing activities has changed by +$117.48 M (+36.10%)
What is Sage Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of SAGE is $81.05 M
What is the all time high quarterly CFI for Sage Therapeutics?
Sage Therapeutics all-time high quarterly cash flow from investing activities is $207.78 M
What is Sage Therapeutics quarterly CFI year-on-year change?
Over the past year, SAGE quarterly cash flow from investing activities has changed by +$81.44 M (+21098.45%)
What is Sage Therapeutics TTM cash flow from investing activities?
The current TTM CFI of SAGE is $262.17 M
What is the all time high TTM CFI for Sage Therapeutics?
Sage Therapeutics all-time high TTM cash flow from investing activities is $573.51 M
What is Sage Therapeutics TTM CFI year-on-year change?
Over the past year, SAGE TTM cash flow from investing activities has changed by -$79.34 M (-23.23%)